Skip to main content
Premium Trial:

Request an Annual Quote

Lark to Provide Novartis Research Foundation with Sequencing Services

Premium

HOUSTON--Building on a prior relationship, Lark Technologies and the Novartis Research Foundation have negotiated a new agreement. Lark will provide DNA sequencing services to support gene discovery efforts at the institute. Novartis will supply biological materials to Lark, which will offer high-throughput sequencing for an undisclosed fee. Novartis has been a client of Lark for several years, said Doug Wheeler, Lark's president and COO.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.